aTYR PHARMA INC Area of Land
aTYR PHARMA INC (ATYR) had Area of Land of 24.87 thousand sqft as of 2024-04-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes
us-gaap:AreaOfLand · last filed 2026-08-07
- 2024-04-30: Area of Land 24.87K sqft.
- 2024-04-01: Area of Land 23.70K sqft; Area of Land as first filed 1.17K sqft.
- 2023-09-30: Area of Land 1.50K sqft.
- 2023-06-30: Area of Land 1.50K sqft.
| Period end | Area of Land | Area of Land as first filed |
|---|---|---|
| 2024-04-30 | 24.87K sqft 10-Q · filed 2026-08-07 | |
| 2024-04-01 | 23.70K sqft 10-Q · filed 2026-08-07 | 1.17K sqft 10-Q · filed 2024-08-13 |
| 2023-09-30 | 1.50K sqft 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 1.50K sqft 10-K · filed 2025-03-13 | |
| 2023-03-13 | 24.49K sqft 10-K · filed 2023-03-14 | |
| 2022-05-31 | 23.70K sqft 10-K · filed 2025-03-13 | |
| 2022-04-30 | 24.87K sqft 10-K · filed 2025-03-13 | |
| 2018-07-31 | 20.51K sqft 10-K · filed 2023-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |